Skip to main content

13-F holdings, Q2 2021

Johnson & Johnson Innovation - JJDC, Inc.

A 13-F is the report large US investment managers file with the SEC each quarter, listing the stocks they held at quarter end.

Reported value
$978.2M
Positions
21
Filed
Data as of

These holdings are as of , 1,960 days ago.

The deadlines for 20 following quarters have passed, and we hold no newer list of holdings from this filer. That can mean it filed a notice instead, stopped reporting, or that our copy is behind.

13-Fs for Q3 2026 are due by .

See this manager's Holder IQ and how the book overlaps yours

Free to start, with no card. Holder IQ scores a manager's past record. It describes the past and is not a recommendation to buy or sell anything. Sign up and you can follow this manager: one notice for each new 13-F, naming what changed and which of those positions you hold or watch.

Top holdings

  1. FATE$293.3M
    3,379,064 shares30% of the book
  2. ARWR$270.1M
    3,260,869 shares27.6% of the book
  3. PTGX$109.9M
    2,449,183 shares11.2% of the book
  4. CVRX$97.9M
    3,495,575 shares10% of the book
  5. LEGN$66.9M
    1,629,173 shares6.8% of the book
  6. MGTX$44.9M
    2,898,550 shares4.6% of the book
  7. VOR$20M
    1,074,658 shares2% of the book
  8. PHGE$11.6M
    2,133,402 shares1.2% of the book
  9. ACET$7.5M
    728,944 shares0.77% of the book
  10. ALDX$4.5M
    394,834 shares0.46% of the book

What changed this quarter

1 new position and 0 sold out, against Q1 2021. Added and trimmed positions use the change in split-adjusted shares at the Q2 2021 implied price; full exits use their Q1 2021 reported value, not sale proceeds.

Largest buys

  • THERAPEUTICS ACQUISITION COR

    +$10.3M

    New

    Your stake and evidence for THERAPEUTICS ACQUISITION COR

    What it means for you

    This filing line has no matched ticker, so your stake is unavailable.

    Use this to decide what to research, rather than as an instruction to copy a trade.

    What happened

    A position newly appears in the Q2 2021 book.

    Displayed change: +$10.3M. The current book reports 1,000,000 shares.

    Why it can matter

    A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.

    How we got this

    A new position uses its current quarter's reported dollar value; this is not the amount spent buying it.

    Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.

    Where the data comes from

    SEC 13F quarter-end holdings for Q1 2021 and Q2 2021; these delayed disclosures omit shorts and many other assets.

    Current source filed .

    Read source filing

    Source filing on SEC.gov

    Technical details

    Reported dollar change: 10274000 USD. Current reported shares: 1000000. Prior shares on current basis: not recorded.

Largest sells

  • SENS

    SENSEONICS HOLDINGS, INC.

    −$1.7M

    -88.9% shares

    Your stake and evidence for SENS

    What it means for you

    This public view does not read your holdings or watchlist; open the member view to check your stake.

    Use this to decide what to research, rather than as an instruction to copy a trade.

    What happened

    Reported shares decreased between Q1 2021 and Q2 2021.

    Displayed change: −$1.7M. The current book reports 54,621 shares.

    Why it can matter

    A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.

    How we got this

    For an added or trimmed position, subtract split-adjusted prior shares from current shares, then multiply by the current book's reported value per share; this is not the execution price.

    54,621 current shares − 492,269 prior shares on the same basis = -437,648 shares.

    Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.

    Where the data comes from

    SEC 13F quarter-end holdings for Q1 2021 and Q2 2021; these delayed disclosures omit shorts and many other assets.

    Current source filed .

    Read source filing

    Source filing on SEC.gov

    Technical details

    Reported dollar change: -1682614.3790849673 USD. Current reported shares: 54621. Prior shares on current basis: 492269.

Not counted as trades: CVRX (newly listed or spun off), NPCE (newly listed or spun off), ZYMERGEN INC. (newly listed or spun off).

All of this comes from the filer's public SEC filings. A 13-F shows long positions in US-listed securities at quarter end and can leave out short positions, cash and non-US holdings, so it is not the whole portfolio. This is filing data, not investment advice.